Literature DB >> 32815103

Metabolomic Analysis of the Improvements in Insulin Secretion and Resistance After Sleeve Gastrectomy: Implications of the Novel Biomarkers.

Yeongkeun Kwon1,2, Mi Jang3, Youngsun Lee4, Jane Ha1,2, Sungsoo Park5,6.   

Abstract

BACKGROUND: Large neutral amino acids (LNAAs) and gut microbial metabolites have been linked to insulin secretion and resistance. We investigated whether baseline LNAAs and kynurenine pathway metabolites and changes in tryptophan-derived gut microbial metabolites (TDGMs), such as indole compounds, were associated with improvements in insulin secretion and resistance after sleeve gastrectomy.
METHODS: In this prospective single-arm longitudinal study, 23 patients with type 2 diabetes underwent sleeve gastrectomy. Twelve diabetes-related amino acid metabolites were quantified before surgery, and the following three indices were assessed as outcome measures: insulinogenic index, homeostasis model assessment-insulin resistance (HOMA-IR), and quantitative insulin sensitivity check index (QUICKI). We also measured changes in TDGMs, including four indole compounds, 3 months after bariatric surgery. A linear regression model and receiver operating characteristic curves were assessed.
RESULTS: The mean age and body mass index of study participants were 41.8 years (standard deviation (SD), 13.1 years) and 38.9 kg/m2 (SD, 5.2 kg/m2), respectively. Several baseline amino acid metabolites were significantly associated with a change in insulin secretion or resistance 3 months after bariatric surgery. Phenylalanine and LNAAs showed superior performance for predicting improvements in insulin secretion and resistance. Among the TDGMs, Δindole-3-propionic acid was significantly associated with the Δinsulinogenic index, and Δindole-3-acetic acid was significantly associated with the ΔHOMA-IR and ΔQUICKI.
CONCLUSIONS: Our findings underscore the importance of baseline amino acid profiles, especially those of LNAAs and phenylalanine, and alterations in TDGMs for improving insulin secretion and resistance in the early postoperative period after sleeve gastrectomy.

Entities:  

Keywords:  Amino acids; Insulin resistance; Insulin secretion; Metabolomics; Sleeve gastrectomy; Type 2 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32815103     DOI: 10.1007/s11695-020-04925-2

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  45 in total

1.  First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis.

Authors:  N Basso; D Capoccia; M Rizzello; F Abbatini; P Mariani; C Maglio; F Coccia; G Borgonuovo; M L De Luca; R Asprino; G Alessandri; G Casella; F Leonetti
Journal:  Surg Endosc       Date:  2011-06-03       Impact factor: 4.584

2.  Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Laura Leccesi; Giuseppe Nanni; Alfons Pomp; Marco Castagneto; Giovanni Ghirlanda; Francesco Rubino
Journal:  N Engl J Med       Date:  2012-03-26       Impact factor: 91.245

3.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

4.  Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.

Authors:  M Nannipieri; S Baldi; A Mari; D Colligiani; D Guarino; S Camastra; E Barsotti; R Berta; D Moriconi; R Bellini; M Anselmino; E Ferrannini
Journal:  J Clin Endocrinol Metab       Date:  2013-09-20       Impact factor: 5.958

5.  Reprogramming of intestinal glucose metabolism and glycemic control in rats after gastric bypass.

Authors:  Nima Saeidi; Luca Meoli; Eirini Nestoridi; Nitin K Gupta; Stephanie Kvas; John Kucharczyk; Ali A Bonab; Alan J Fischman; Martin L Yarmush; Nicholas Stylopoulos
Journal:  Science       Date:  2013-07-26       Impact factor: 47.728

6.  Metabolite profiles and the risk of developing diabetes.

Authors:  Thomas J Wang; Martin G Larson; Ramachandran S Vasan; Susan Cheng; Eugene P Rhee; Elizabeth McCabe; Gregory D Lewis; Caroline S Fox; Paul F Jacques; Céline Fernandez; Christopher J O'Donnell; Stephen A Carr; Vamsi K Mootha; Jose C Florez; Amanda Souza; Olle Melander; Clary B Clish; Robert E Gerszten
Journal:  Nat Med       Date:  2011-03-20       Impact factor: 53.440

7.  The effects of bariatric surgery on pancreatic lipid metabolism and blood flow.

Authors:  Henri Honka; Jukka Koffert; Jarna C Hannukainen; Jetro J Tuulari; Henry K Karlsson; Heidi Immonen; Vesa Oikonen; Tuula Tolvanen; Minna Soinio; Paulina Salminen; Nobu Kudomi; Andrea Mari; Patricia Iozzo; Pirjo Nuutila
Journal:  J Clin Endocrinol Metab       Date:  2015-03-03       Impact factor: 5.958

8.  Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes.

Authors:  F Abbatini; M Rizzello; G Casella; G Alessandri; D Capoccia; F Leonetti; N Basso
Journal:  Surg Endosc       Date:  2009-10-29       Impact factor: 4.584

9.  Early postoperative insulin-resistance changes after sleeve gastrectomy.

Authors:  Mario Rizzello; Francesca Abbatini; Giovanni Casella; Giorgio Alessandri; Aldo Fantini; Frida Leonetti; Nicola Basso
Journal:  Obes Surg       Date:  2009-11-15       Impact factor: 4.129

10.  FXR is a molecular target for the effects of vertical sleeve gastrectomy.

Authors:  Karen K Ryan; Valentina Tremaroli; Christoffer Clemmensen; Petia Kovatcheva-Datchary; Andriy Myronovych; Rebekah Karns; Hilary E Wilson-Pérez; Darleen A Sandoval; Rohit Kohli; Fredrik Bäckhed; Randy J Seeley
Journal:  Nature       Date:  2014-03-26       Impact factor: 49.962

View more
  4 in total

Review 1.  Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes.

Authors:  Jane Ha; Yeongkeun Kwon; Sungsoo Park
Journal:  Obes Surg       Date:  2021-07-27       Impact factor: 4.129

2.  Metabolomics in Bariatric and Metabolic Surgery Research and the Potential of Deep Learning in Bridging the Gap.

Authors:  Athanasios G Pantelis
Journal:  Metabolites       Date:  2022-05-19

Review 3.  Metabolomic signatures after bariatric surgery - a systematic review.

Authors:  Matilde Vaz; Sofia S Pereira; Mariana P Monteiro
Journal:  Rev Endocr Metab Disord       Date:  2021-12-02       Impact factor: 9.306

4.  Metabolomics analysis of stool in rats with type 2 diabetes mellitus after single-anastomosis duodenal-ileal bypass with sleeve gastrectomy.

Authors:  Lun Wang; Zeyu Wang; Yang Yu; Zhaoheng Ren; Yongheng Jia; Jinfa Wang; Shixing Li; Tao Jiang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-20       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.